Now is Endocrinología, Diabetes y Nutrición (English ed.). More information
Endocrinología y Nutrición is the official publication of the Spanish Society of Endocrinology and Nutrition (SEEN) and the Diabetes Spanish Society (SED) . It is the best journal to keep up to date with endocrine pathophysiology both in the clinical and in the research field. It publishes the best original articles of large research institutions, as well as prestigious reviews.Indexed in:
Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS
See moreFollow us:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2017
1.268
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2017
0.28
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2017
0.383
View more metrics
Discontinued publication
Hide
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Endocrinología y Nutrición (English Edition)
Prevalence of overweight and obesity in children and adolescents aged 2–16 years
Emilio García García, María-Ángeles Vázquez López, Rafael Galera Martínez, Irene Alias, Manuel Martín González, Antonio Bonillo Perales, José Eugenio Cabrera Sevilla, Icíar García Escobar, Sara Gómez Bueno, Encarnación López Ruzafa, Francisco-Javier Muñoz Vico, Patricia Oliva Pérez, María Ortiz Pérez, Juan Poveda González, Marisa Rodríguez Lucenilla, Firma-Isabel Rodríguez Sánchez, Ana Ruiz Sánchez, Lucía Ruiz Tudela, María I. Sáez, Jorge Salvador, Sara Torrico
10.1016/j.endoen.2012.09.001
Endocrinol Nutr 2013;60:121-6
Full text access
Vitamin B 12 in type 2 diabetic patients treated with metformin
José María Calvo Romero, José Manuel Ramiro Lozano
10.1016/j.endoen.2012.06.005
Endocrinol Nutr 2012;59:487-90
Full text access
Medium-term evaluation of an educational intervention on dietary and physical exercise habits in schoolchildren: The Avall 2 study
Esteve Llargués, Assumpta Recasens, Rosa Franco, Anna Nadal, Maria Vila, M. José Pérez, Isabel Recasens, Gemma Salvador, Jaume Serra, Eulàlia Roure, Conxa Castell
10.1016/j.endoen.2012.06.004
Endocrinol Nutr 2012;59:288-95
Full text access
Breaking therapeutic inertia: Should metabolic surgery be considered one more option for the treatment of type 2 diabetes mellitus?
Albert Lecube, Bartolomé Burguera, Miguel Ángel Rubio
10.1016/j.endoen.2012.06.003
Endocrinol Nutr 2012;59:281-3
Full text access
Type 2 diabetes and the lung: A bidirectional relationship
Gabriel Sampol, Albert Lecube
10.1016/j.endoen.2012.02.003
Endocrinol Nutr 2012;59:95-7
Full text access
Associations between diet quality, health status and diabetic complications in patients with type 2 diabetes and comorbid obesity
Apostolis Mangou, Maria G. Grammatikopoulou, Daphne Mirkopoulou, Nikolaos Sailer, Charalambos Kotzamanidis, Maria Tsigga
10.1016/j.endoen.2011.10.002
Endocrinol Nutr 2012;59:109-16
Full text access
Glucocentricity or adipocentricity: A critical view of consensus and clinical guidelines for the treatment of type 2 diabetes mellitus
Juan José Gorgojo Martínez
10.1016/j.endoen.2011.09.002
Endocrinol Nutr 2011;58:541-9
Full text access
Benefits of a home-based physical exercise program in elderly subjects with type 2 diabetes mellitus
Juan Carlos Ferrer-García, Patricia Sánchez López, Carlos Pablos-Abella, Raquel Albalat-Galera, Laura Elvira-Macagno, Carlos Sánchez-Juan, Ana Pablos-Monzó
10.1016/j.endoen.2011.05.007
Endocrinol Nutr 2011;58:387-94
Full text access
Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus
Gordon Goodall, María Costi, Louise Timlin, Jesús Reviriego, José Antonio Sacristán, Jayne Smith-Palmer, Tatiana Dilla
10.1016/j.endoen.2011.04.002
Endocrinol Nutr 2011;58:331-40
Full text access
Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease
Antonio Pérez, Cintia González Blanco, Miguel Ángel Hernández-Presa, José Chaves
10.1016/S2173-5093(11)70061-7
Endocrinol Nutr 2011;58:283-90
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History